EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 10 (Octobre 2013) Med Sci (Paris), 29 10 (2013) 861-867 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 10, Octobre 2013
Page(s) 861 - 867
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20132910013
Published online 18 October 2013
  1. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002 ; 297 : 2056–2060. [CrossRef] [PubMed] [Google Scholar]
  2. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005 ; 435 : 834–838. [CrossRef] [PubMed] [Google Scholar]
  3. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006 ; 103 : 2257–2261. [CrossRef] [Google Scholar]
  4. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008 ; 47 : 1955–1963. [CrossRef] [PubMed] [Google Scholar]
  5. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 ; 25 : 2537–2545. [CrossRef] [PubMed] [Google Scholar]
  6. Boyault S, Rickman DS, de Reynies A, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007 ; 45 : 42–52. [CrossRef] [PubMed] [Google Scholar]
  7. Sekine S, Ogawa R, Ito R, et al. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 2009 ; 136 : 2304–2315.e1–4. [CrossRef] [PubMed] [Google Scholar]
  8. Sekine S, Ogawa R, McManus MT, et al. Dicer is required for proper liver zonation. J Pathol 2009 ; 219 : 365–372. [CrossRef] [PubMed] [Google Scholar]
  9. Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012 ; 142 : 1431–1443. [CrossRef] [PubMed] [Google Scholar]
  10. Wen J, Friedman JR. miR-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Investig 2012 ; 122 : 2773–2776. [CrossRef] [Google Scholar]
  11. Vaulont S. miR-122, un microARN « à tout fer ». Med Sci (Paris) 2011 ; 27 : 704–706. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Law PT, Wong N. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 2011 ; 26 : 437–449. [CrossRef] [PubMed] [Google Scholar]
  13. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010 ; 327 : 198–201. [CrossRef] [PubMed] [Google Scholar]
  14. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013 ; 368 : 1685–1694. [CrossRef] [PubMed] [Google Scholar]
  15. Bala S, Marcos M, Kodys K, et al. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 2011 ; 286 : 1436–1444. [CrossRef] [PubMed] [Google Scholar]
  16. Bala S, Petrasek J, Mundkur S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012 ; 56 : 1946–1957. [CrossRef] [PubMed] [Google Scholar]
  17. Yan XL, Jia YL, Chen L, et al. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4-miR155-SOCS1-MMP9 axis. Hepatology 2013 ; doi : 10.1002/hep.26257. [Google Scholar]
  18. Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011 ; 19 : 232–243. [CrossRef] [PubMed] [Google Scholar]
  19. Xiong Y, Fang JH, Yun JP, et al. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010 ; 51 : 836–845. [PubMed] [Google Scholar]
  20. Pineau P, Volinia S, McJunkin K, et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010 ; 107 : 264–269. [CrossRef] [Google Scholar]
  21. Cairo S, Wang Y, de Reynies A, et al. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci USA 2010 ; 107 : 20471–20476. [CrossRef] [Google Scholar]
  22. Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 2013 ; 57 : 840–847. [CrossRef] [PubMed] [Google Scholar]
  23. Zucman-Rossi J. Molecular classification of hepatocellular carcinoma. Dig Liver Dis 2010 ; 42 Suppl 3 : S235–S241. [CrossRef] [PubMed] [Google Scholar]
  24. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009 ; 136 : 683–693. [CrossRef] [PubMed] [Google Scholar]
  25. Ladeiro Y, Zucman-Rossi J. Micro-ARN (miARN) et cancer : le cas des tumeurs hépatocellulaires. Med Sci (Paris) 2009 ; 25 : 467–472. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  26. Wong CM, Wong CC, Lee JM, et al. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis. Hepatology 2012 ; 55 : 1453–1461. [CrossRef] [PubMed] [Google Scholar]
  27. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008 ; 47 : 897–907. [CrossRef] [PubMed] [Google Scholar]
  28. Li LM, Hu ZB, Zhou ZX, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010 ; 70 : 9798–9807. [CrossRef] [PubMed] [Google Scholar]
  29. Zhou J, Yu L, Gao X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011 ; 29 : 4781–4788. [CrossRef] [PubMed] [Google Scholar]
  30. Park JK, Kogure T, Nuovo GJ, et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 2011 ; 71 : 7608–7616. [CrossRef] [PubMed] [Google Scholar]
  31. Obad S, dos Santos CO, Petri A, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011 ; 43 : 371–378. [CrossRef] [PubMed] [Google Scholar]
  32. Kota J, Chivukula RR, O’Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009 ; 137 : 1005–1017. [CrossRef] [PubMed] [Google Scholar]
  33. Hatziapostolou M, Polytarchou C, Aggelidou E, et al. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011 ; 147 : 1233–1247. [CrossRef] [PubMed] [Google Scholar]
  34. Muller S, Raman Pandey R, Pillai RS. Les piARN forgent un système immunitaire pour le génome. Med Sci (Paris) 2013 ; 29 : 487–494. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  35. Lemaigre F. Le développement des lignages hépatiques dans le foie normal et durant la régénération. Med Sci (Paris) 2012 ; 28 : 958–962. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.